Global Continuous Renal Replacement Therapy Market was valued at around USD 1.5 billion in the year 2016 and is anticipated to witness a steep rise by generating an estimated revenue of US$ XX. XX over the forecast period. According to latest study conducted by our analysts and industry experts, global XXXX market is expected to grow at a CAGR of 6.5% during the forecast period, i.e. 2017-2025.

Continuous renal replacement therapy is a type of dialysis used for critically ill patients suffering from acute kidney injury, specifically for hemodynamically unstable patients. Continuous renal replacement therapy filters the blood by removing excess water, harmful waste and toxins including urea and creatinine. Continuous renal replacement therapy is used in the hospitals and clinical dialysis centers for the patients suffering from acute kidney injury and require frequent dialysis. Several diseases like heart attack leads to decreased blood flow to the kidney leading to acute kidney failure. Acute tubular necrosis and sudden dehydration can also cause damage to the kidney. Acute kidney injury if not treated may lead to metabolic acidosis, high potassium levels, uremia, etc.  

Global Continuous Renal Replacement Therapy Market Opportunities and Challenges Analysis by 2017 - 2025

Market Dynamics:

Increased awareness and technological advancement in the continuous renal replacement therapy machine has led to better treatment of acute kidney injury. Particularly the patients who hemodynamically unstable and cannot handle changes in the bodily fluids. The continuous and slow replacement of solutes and other nutrients in the body is an advantage of continuous renal replacement therapy.

The continuous renal replacement therapy must facilitate the fluid and solute homeostasis of the patient’s body along with maintaining the nutrition and vital organ functions. Although, continuous renal replacement therapy has been to thought to be superior to intermittent hemodialysis. Anticoagulation, biocompatibility, mobility and high cost of therapy are some of the obstacles which still needs to be addressed.

Market Segmentation:

Continuous renal replacement therapy market is segmented into:

Dialysate fluids has a consequential role in determining the biocompatibility of hemodialysis system. Dialysate fluids can be adjusted as per the patient’s individual needs. Dialysate component is made by mixing two concentrate components, i.e., bicarbonate component which contains sodium bicarbonate and sodium chloride and Acid component which includes chloride salts of sodium, potassium, acetate and glucose. Hemofilter is a semi permeable membrane used in hemofiltration for collecting excess water and waste material. Hemofilter is used in hemofiltration technique where the patient’s blood is passed through a set of tubing via a machine to the semi permeable membrane acting as a filter (Hemofilter) and the waste material and water gets collected and called as ultrafiltrate. Renal replacement fluids includes solutes of potassium, magnesium, calcium, bicarbonate and dextrose and differ in concentration with dialysate fluids. Renal replacement fluids are lost during convective clearance and needs to be replenished depending upon the patients physiology. Anticoagulants, most commonly heparin is administered as an anticoagulant during continuous renal replacement therapy to avoid clotting of blood. Heparin binds and inhibits antithrombin to activate the process of coagulation. Citrate can also be used as an anticoagulant. Bloodline set is a collection of different components of continuous renal replacement therapy machine. This includes a set of connectors, injection ports, line clamps, arterial bubble catcher, single needle chamber, waste bags and other accessories and disposables. Disposables are expected to register highest CAGR during the forecast period in terms of product type, owing to their single use and shorter life span.

On the basis of modality, continuous renal replacement market therapy is segmented into:

Slow continuous ultrafiltration involves removal of water from the patient’s blood as it passes through the filter. Slow continuous ultrafiltration is designed only for removal of surplus water from the body. Continuous Venovenous Hemodialysis is a diffusion-based therapy where the blood flows through the blood compartment and the dialysate fluid flows counter currently. The counter current flow maximizes the diffusion gradient resulting in removal of toxins. The process of Continuous Venovenous Hemofiltration provides high ultrafiltration rates leading to survival benefits in acute renal failure. It removes excess water along with the solutes from the blood. Artificial kidneys lack the properties of reabsorption and hence loss of excessive water must be replenished in the patient’s body. The process of Continuous Venovenous Hemodiafiltration follows the principle of diffusion and convection, i.e., hemofiltration and hemodialysis using a highly efficient hemodiafilter to remove and replace solutes and fluids from within the blood. In terms of modality, continuous venovenous hemodiafiltration is expected to capture the highest CAGR during the forecast period, owing to its added advantage of convection and diffusion for the removal of solutes.

Regional Insights:

North America and Europe accounts for the largest continuous renal replacement therapy market. Presence of key companies involved in the production of continuous renal replacement therapy machine including Prismaflex (Baxter Medical), Diapact system (B-Braun), Nxstage system One (NSO Nxstage Medical), MARS system (Gambro) is one key factor for the growth in this region. Spectral Medical Inc. has expressed its intent to introduce its continuous renal replacement therapy machine called S.A.M. (Spectral Apheresis Machine) in the coming months in the North American market.

Global Continuous Renal Replacement Therapy Market Size, Share & Opportunities Analysis By Region 2017

Continuous Renal Replacement Therapy Market Study Objectives

1. To forecast the market size of continuous renal replacement therapy market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of continuous renal replacement therapy market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of continuous renal replacement therapy market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of continuous renal replacement therapy market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the continuous renal replacement therapy market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Bottom-up and top-down are two main approaches that were taken into account to anticipate and validate the market size of continuous renal replacement therapy market, and to reach the anticipated market size of several dependent submarkets. The research and study involved massive utilization of secondary data sources, several directories, private and government websites, and authentic databases, to collect or gather market-oriented as well as technical information for the study of continuous renal replacement therapy market commercially.

Global Key Players

Key vendors in the market for continuous renal replacement therapy are developing new and innovative techniques to provide higher precision, improved support to the clinicians and better handling. Some of the key vendors for continuous renal replacement therapy are B. Braun Melsungen AG, Gambro Inc., Baxter Medical, Asahi Kasei Corp., Nxstage Medical Inc., Toray Medical Co., Fresenius Medical Care AG & Co. KGaA, NIPRO Corporation, Spectral Medical Inc., Bellco S.r.l. and Medtronic plc.

Global Continuous Renal Replacement Therapy Market Report Offer You!

Global Continuous Renal Replacement Therapy Market size report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast.

The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Why You Should Choose us?
• We offer the best industry research services.
• Our panel of experts has tremendous experience in their respective fields
• We use advanced analytical tools to provide highly personalized industry intelligence research.
• We provide easy-to- use information.
• Qualitative and Quantitative market research
• Market size assessment across various segments
• Potential early warning signals posed by existing market players
• Providing benchmark metrics by comparing an organization across the industry
• Competitive assessment which may impact business and product evaluation
• Insights about government or legal changes that might impact market statistics
• Operational cost optimization strategies